CNTX vs GRMN · $55.1M cap vs P/E 28, rev $7.25B
Context Therapeutics Inc (CNTX) versus Garmin Ltd (GRMN) — a side-by-side from cached financials, not a winner call.
Context Therapeutics Inc (CNTX) is a biotechnology company listed on NASDAQ.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
CNTX does not have a complete income-statement cache yet.
Latest reported GRMN revenue for 2025-12-27 was $7.25B. Net income was $1.66B. Revenue was up 15.1% from 2024-12-28 to 2025-12-27. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
CNTX currently screens at market cap $55.1M. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Not investment advice. Open the CNTX and GRMN stock pages for the full models.
Not investment advice.